By Dr. Carla Grandori | President and Scientific Director
Project Neuroblastoma. Cure First launched the Neuroblastoma campaign on Global Giving to raise awareness and funding to apply high-throughput technologies to precisely identify targeted and potentially less-toxic therapies for children with Neuroblastoma. Thanks to the initial funding of $6,175 we are now in a position to purchase reagents and retain talented young researchers with expertise in culturing Neuroblastoma cells and in analyzing the results. Our Project Leader, Dr. Carla Grandori, has met with pediatric oncologist experts in Neuroblastoma and has initiated collaborations across the country. We now have all in place to tackle Neuroblastoma and are hopeful to reach the $50,000 goal to fully launch the project. Thank you to our 52 donors for your generosity and interest in children’s cancers!
Carla Grandori, MD, PhD
President and Scientific Director, Cure First
website: www.curefirst.org | fb: facebook.com/CureFirst | twitter: @Cure_First
A precise path to healthier and effective cancer treatments.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
